Modulation of cytotoxic drug activity by mitotane and lonidamine in human adrenocortical carcinoma cells

International Journal of Oncology

Volumn 14, Issue 1, 1999, Pages 133-138

  Zaffaroni, Nadia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adrenocortical carcinoma; Drug combinations; Lonidamine; Mitotane

Indexed keywords

ANTINEOPLASTIC AGENT; INDAZOLE DERIVATIVE; LONIDAMINE; MITOTANE;

ADRENAL CORTEX TUMOR; ARTICLE; CELL CULTURE; DRUG POTENTIATION; HUMAN; PATHOLOGY;

ADRENAL CORTEX NEOPLASMS; ANTINEOPLASTIC AGENTS; DRUG SYNERGISM; HUMANS; INDAZOLES; MITOTANE; TUMOR CELLS, CULTURED;

EID: 0032608639     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Samaan NA and Hickcy RC: Adrenal cortical carcinoma. Semin Oncol 14: 292-296, 1987.
2. Lee JE, Berger DU, El-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA and Evans DB: Surgical management, DNA content, and patient survival in adrcnocortical carcinoma. Surgery 118: 1090-1098, 1995..